Jessica Meng
Fortune : 8 M $ au 31/08/2026
Fortune : 8 M $ au 31/08/2026
Jessica Meng is Chief Commercial Officer at CareDx, Inc. since 2024.
Former roles include Vice President-Marketing at Veracyte, Inc. from 2018 to 2020 and Chief Commercial Officer at Delfi Diagnostics, Inc. Education includes an undergraduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CAREDX, INC. 0,31 % | 12/09/2026 | 161 599 ( 0,31 % ) | 8 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CAREDX, INC. | Corporate Officer/Principal | 12/09/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| VERACYTE, INC. | Sales & Marketing | 01/05/2020 |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national